CELLECTAR BIOSCIENCES, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.375 USD | +6.13% |
|
+5.16% | +21.48% |
| May. 14 | Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| May. 14 | Cellectar Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-09 | 2024-05-10 | 2024-05-13 | 2024-05-14 | 2024-05-15 | |
|---|---|---|---|---|---|
| Last | 3.24 $ | 3.07 $ | 3.06 $ | 3.18 $ | 3.365 $ |
| Volume | 180 512 | 1 118 622 | 640 388 | 677 414 | 1 009 298 |
| Change | +1.25% | -5.25% | -0.33% | +3.92% | +6.13% |
| Opening | 3.20 | 3.25 | 3.08 | 3.02 | 3.25 |
| High | 3.25 | 3.25 | 3.16 | 3.22 | 3.49 |
| Low | 3.18 | 3.05 | 2.98 | 3.00 | 3.23 |
Performance
| 1 day | +5.50% | ||
| 1 week | +5.16% | ||
| Current month | +8.90% | ||
| 1 month | +1.36% | ||
| 3 months | -6.27% | ||
| 6 months | +69.95% | ||
| Current year | +21.48% | ||
| 1 year | +143.84% | ||
| 3 years | -73.91% | ||
| 5 years | -88.07% | ||
| 10 years | -99.95% |
Volumes
marketsDaily volume
1 009 298
Estimated daily volume
1 087 716
Avg. Volume 20 sessions
697 425
Daily volume ratio
1.56
Avg. Volume 20 sessions USD
2 353 809.38
Record volume 1
33 922 487
Record volume 2
31 005 120
Record volume 3
5 057 290
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Capitalization (USD)
113 999 578
Net sales (USD)
0
Number of employees
20
Sales / Employee (USD)
0
Free-Float
88.19 %
Free-Float capitalization (USD)
90 471 973
Average Daily Capital Traded
2.06%
Highs and lows
1 week
2.98
3.49
1 month
2.943.51
Current year
2.554.45
1 year
1.364.45
3 years
1.2518.40
5 years
1.2533.30
10 years
1.257 680.00
Indicators
Moving average 5 days
3.15
Moving average 20 days
3.17
Moving average 50 days
3.53
Moving average 100 days
3.46
Price spread / (MMA5)
-6.67%
Price spread / (MMA20)
-6.22%
Price spread / (MMA50)
+4.59%
Price spread / (MMA100)
+2.52%
STIM
RSI 9 days
37.32
RSI 14 days
40.05
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +6.13% | +5.16% | +21.48% | +143.84% | 114M | ||
| +0.78% | +3.84% | +31.37% | +57.85% | 588B | ||
| +0.72% | +2.26% | -2.82% | -4.53% | 364B | ||
| +2.27% | +1.32% | +20.40% | +12.80% | 326B | ||
| +1.36% | +1.85% | +5.45% | +11.48% | 285B | ||
| -0.60% | -0.75% | +14.83% | +1.43% | 239B | ||
| -0.20% | +3.05% | +9.93% | +0.88% | 210B | ||
| +1.29% | +2.34% | -6.95% | -19.96% | 200B | ||
| +2.94% | +4.00% | +10.96% | +36.85% | 167B | ||
| +1.39% | +1.87% | +0.03% | -22.50% | 161B | ||
| -1.23% | -2.71% | +0.89% | -9.15% | 124B | ||
| +0.14% | +2.20% | +24.98% | +23.33% | 92.88B | ||
| -0.35% | +1.89% | -13.28% | -34.73% | 90.63B | ||
| -0.65% | +3.70% | -16.90% | -14.11% | 84.28B | ||
| +1.31% | +3.04% | +41.68% | +19.26% | 66.36B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| Average | +0.94% | +1.44% | +9.47% | +13.52% | ||
| Weighted average by Cap. | +0.84% | +1.68% | +11.43% | +12.29% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
511.gp9l_Qgk9_OIPaQFPZkOWfQ8pTHQNAesuzb2bYW8yuI.6dpdzEpolsq4ROVmTMlrKZkLylWyWG_v8luQPMnsmqD00SG4QHObur4L5Q
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 03:31:14 pm | 3.365 | 100 | 961,589 |
| 03:31:01 pm | 3.37 | 100 | 961,489 |
| 03:30:57 pm | 3.365 | 100 | 961,389 |
| 03:30:29 pm | 3.365 | 100 | 961,289 |
| 03:30:18 pm | 3.365 | 100 | 961,189 |
| 03:30:14 pm | 3.365 | 100 | 961,089 |
| 03:30:05 pm | 3.36 | 123 | 960,989 |
| 03:30:05 pm | 3.36 | 100 | 960,866 |
| 03:30:05 pm | 3.36 | 567 | 960,766 |
| 03:30:05 pm | 3.36 | 380 | 960,199 |
Monthly variations
Annual change
| 2024 | +14.80% | ||
| 2023 | +61.99% | ||
| 2022 | -74.25% | ||
| 2021 | -68.08% | ||
| 2020 | -7.56% | ||
| 2019 | +45.16% | ||
| 2018 | -88.69% | ||
| 2017 | +12.30% | ||
| 2016 | -83.40% | ||
| 2015 | -76.21% | ||
| 2014 | -58.24% | ||
| 2013 | -50.00% | ||
| 2012 | +68.18% | ||
| 2011 | -85.33% |
- Stock Market
- Equities
- CLRB Stock
- Quotes Cellectar Biosciences, Inc.
